| Practical
recommendations for hormone replacement therapy in the peri- and postmenopause Recommendations from an Expert Workshop, February 2004 The following recommendations provide guidance to medical practitioners in the appropriate use of estrogen and progestogen therapy in peri- and postmenopausal women. They are derived from a meeting in February 2004 of internationally recognized experts who reviewed results of the recent clinical trials, the conclusions of which have led to much confusion and alarm among women and their doctors. A personal initiative for women's health: to challenge the Women's Health Initiative A. R. Genazzani, Editor-in-Chief, and M. Gambacciani, Menopause Clinic, Pisa, Italy In the USA, a randomized, placebo-controlled, double-blind trial to evaluate the effects of a combination estrogen-progestogen therapy in postmenopausal women was stopped after 5.2 years by the Women's Health Initiative (WHI) because the health risks were considered higher than the health benefits by a small margin... (continue) |